Skip to content

Panel Discussion: Improving Current Standard of Care

Time: 2:30 pm
day: Day One


  • Moving towards personalised treatment options
  • What are the roles of each therapy at what stage
  • Is there a need for an extended factor half-life product?
  • Defining protection and goal for treatment
  • New product treatment paradigm
  • How are novel therapies impacting the market